Top Abstract Purchase Related
Home
>
Node
>
Subnode

The potential of neutron capture therapy in the management of uncontrollable localised tumours

Allen, B.J.

Australasian Radiology 34(4): 297-305

1990

ISSN/ISBN: 0004-8461
PMID: 1965483
Document Number: 356240
The role of Neutron Capture Therapy for the treatment of uncontrollable, localized tumors is examined. Several boron carrier biochemicals are already in use for the selective accumulation of boron in cancer cells, and therapeutic boron concentrations have been achieved in glioblastoma and melanoma in animal models and in patients. Local control of glioblastoma and subcutaneous melanoma has been reported after thermal neutron irradiation. Different neutron beam requirements apply for the treatment of these cancers, in the former case a thermal beam is adequate but a more penetrating epithermal beam is needed for the treatment of deep-seated tumors. A thermal facility for small animal irradiation is available in Australia, and the development of a patient thermal/epithermal facility is under active consideration.

Document emailed within 1 workday
Secure & encrypted payments

Tamat, S.R.; Patwardhan, A.; Moore, D.E.; Kabral, A.; Bradstock, K.; Hersey, P.; Allen, B.J. 1989: Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 145-147
Yong, J.H.; Barth, R.F.; Wyzlic, I.M.; Soloway, A.H.; Rotaru, J.H. 1995: In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy Anticancer Research 15(5b): 2033-2038
Wambersie, A.; Menzel, H.G. 1993: RBE in fast neutron therapy and in boron neutron capture therapy. a useful concept or a misuse? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 169(1): 57-64
Matalka, K.Z.; Bailey, M.Q.; Barth, R.F.; Staubus, A.E.; Soloway, A.H.; Moeschberger, M.L.; Coderre, J.A.; Rofstad, E.K. 1993: Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent Cancer Research 53(14): 3308-3313
Takagaki, M.; Ono, K.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. 1996: Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors Cancer Research 56(9): 2017-2020
Gahbauer, R.; Kanellitsas, C.; Blue, T.; Wang, C.; Clendenon, N.; Fairchild, R.; Laster, B.; McGregor, J.; Goodman, J. 1989: Dose bracketing in boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 229-230
Hatanaka, H.; Amano, K.; Sano, K.; Mogami, H.; Hayakawa, T. 1974: Boron-10-slow neutron capture therapy for brain tumors No Shinkei Geka. Neurological Surgery 2(1): 7-16
Hatanaka, H.; Sano, K.; Yasukochi, H. 1988: Boron-neutron capture therapy in brain tumors and other cancers--a radiosurgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Pt: 2-2): 1115-1123
Matsumura, A.; Zhang, T.; Nakai, K.; Endo, K.; Kumada, H.; Yamamoto, T.; Yoshida, F.; Sakurai, Y.; Yamamoto, K.; Nose, T. 2005: Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study Journal of Experimental and Clinical Cancer Research: Cr 24(1): 93-98
Dorn, R.V.; Spickard, J.H.; Griebenow, M.L. 1989: A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 233-234
Mill, A.J. 1989: Biological effects of intermediate-energy neutrons and their relevance to boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 193-196
Al-Samarrai, S.F.; Takeuchi, A.; Hatanaka, H. 1975: Electron microscopic study on the response of the normal canine brain to boron-neutron capture therapy Gan 66(6): 663-672
Laster, B.H.; Kahl, S.B.; Popenoe, E.A.; Pate, D.W.; Fairchild, R.G. 1991: Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture Cancer Research 51(17): 4588-4593
Wambersie, A.; Scalliet, P. 1989: Clinical implementation in BNCT (boron neutron capture therapy): fractionated versus protracted low dose rate irradiation Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(5): 407-411
Montagno, E.d.A.; Moreira Filho, L.; Hatanaka, H. 1989: Three cases of terminal stage malignant gliomas in which the diffusely disseminated intraventricular tumors became the target of boron neutron capture therapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(2-3): 238-240
Soloway, A.H..; Tjarks, W.; Barnum, B.A..; Rong, F-Guang.; Barth, R.F..; Codogni, I.M..; Wilson, J..Gerald. 1998: The Chemistry of Neutron Capture Therapy. (Chem. Rev. 1998, 98, 1515. Published on the Web May 20, 1998) Chemical Reviews 98(6): 2389-2390
Schwarz, R.; Brockmann, W.P.; Junker, A. 1989: Results of fast neutron therapy of adenoid-cystic carcinomas of the head and neck at the neutron therapy facility Hamburg-Eppendorf Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 165(4): 313-314
Yong, J.H.; Barth, R.F.; Rotaru, J.H.; Wyzlic, I.M.; Soloway, A.H. 1995: Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy Anticancer Research 15(5b): 2039-2043
Verset, G.; Borbath, I.; Delaunoit, T.; Demetter, P.; Demolin, G.; Hendlisz, A.; Pattyn, P.; Pauwels, S.; Peeters, M.; Roeyen, G.; Van Cutsem, E.; Van Hootegem, P.; Verslype, C.; Van Laethem, J.L. 2009: The potential role of targeted therapies in the management of neuroendocrine tumours Acta Gastro-Enterologica Belgica 72(1): 59-62
Regel, K.; Abel, H. 1979: Neutron therapy in the GDR. IX. About the accuracy of neutron dosimeter systems Archiv für Geschwulstforschung 49(4): 339-346